Alkyl deoxyglycoside-polymyxin combinations against critical priority carbapenem-resistant gram-negative bacteria

被引:0
|
作者
de Matos, Ana M. [1 ]
Calado, Patricia [1 ]
Miranda, Monica [1 ]
Almeida, Rita [1 ]
Rauter, Amelia P. [1 ]
Oliveira, M. Conceicao [2 ]
Manageiro, Vera [3 ,4 ,5 ]
Canica, Manuela [3 ,4 ,5 ,6 ]
机构
[1] Univ Lisbon, Fac Ciencias, Ctr Quim Estrutural,Dept Quim & Bioquim, Inst Mol Sci, P-1749016 Lisbon, Portugal
[2] Inst Super Tecn, Inst Mol Sci, Ctr Quim Estrutural, Ave Rovisco Pais, P-1049001 Lisbon, Portugal
[3] Natl Inst Hlth Dr Ricardo Jorge, Dept Infect Dis, Natl Reference Lab Antibiot Resistances & Healthca, P-1649016 Lisbon, Portugal
[4] Univ Porto, Inst Agr & Agrifood Sci & Technol, Ctr Studies Anim Sci, Porto, Portugal
[5] Associate Lab Anim & Vet Sci, AL4Anim, Lisbon, Portugal
[6] Univ Lisbon, Fac Vet Med, Ctr Interdisciplinary Res Anim Hlth, CIISA, Lisbon, Portugal
关键词
ENTEROBACTER-CLOACAE; MULTIDRUG-RESISTANCE; RISK-FACTORS; NEPHROTOXICITY; EPIDEMIOLOGY; INFECTIONS; GLYCOSIDES; COLISTIN; THERAPY; POTENT;
D O I
10.1038/s41598-024-51428-6
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The escalating antimicrobial resistance crisis urges the development of new antibacterial treatments with innovative mechanisms of action, particularly against the critical priority carbapenem-resistant Acinetobacter baumannii (CRAB), Pseudomonas aeruginosa (CRPA) and Enterobacteriaceae (CRE). Membrane-disrupting dodecyl deoxyglycosides have been reported for their interesting phosphatidylethanolamine-associated bactericidal activity against Gram-positive strains; however, their inability to penetrate the Gram-negative outer membrane (OM) renders them useless against the most challenging pathogens. Aiming to repurpose alkyl deoxyglycosides against Gram-negative bacteria, this study investigates the antimicrobial effects of five reference compounds with different deoxygenation patterns or anomeric configurations in combination with polymyxins as adjuvants for enhanced OM permeability. The generation of the lead 4,6-dideoxy scaffold was optimized through a simultaneous dideoxygenation step and applied to the synthesis of a novel alkyl 4,6-dideoxy C-glycoside 5, herein reported for the first time. When combined with subtherapeutic colistin concentrations, most glycosides demonstrated potent antimicrobial activity against several multidrug-resistant clinical isolates of CRAB, CRE and CRPA exhibiting distinct carbapenem resistance mechanisms, together with acceptable cytotoxicity against human HEK-293T and Caco-2 cells. The novel 4,6-dideoxy C-glycoside 5 emerged as the most promising prototype structure for further development (MIC 3.1 mu g/mL when combined with colistin 0.5 mu g/mL against CRPA or 0.25 mu g/mL against several CRE and CRAB strains), highlighting the potential of C-glycosylation for an improved bioactive profile. This study is the first to show the potential of IM-targeting carbohydrate-based compounds for the treatment of infections caused by MDR Gram-negative pathogens of clinical importance.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Evaluation of Brilliance CRE Agar for the detection of carbapenem-resistant Gram-negative bacteria
    Bracco, Silvia
    Migliavacca, Roberta
    Pini, Beatrice
    Corbo, Nicoletta
    Nucleo, Elisabetta
    Brigante, Gioconda
    Piazza, Aurora
    Micheletti, Piero
    Luzzaro, Francesco
    [J]. NEW MICROBIOLOGICA, 2013, 36 (02): : 181 - 186
  • [32] Synergistic Activity of Cefiderocol in Combination with Avibactam, Sulbactam or Tazobactam against Carbapenem-Resistant Gram-Negative Bacteria
    Lewis, Russell E.
    Palombo, Marta
    Diani, Erica
    Secci, Benedetta
    Gibellini, Davide
    Gaibani, Paolo
    [J]. CELLS, 2024, 13 (16)
  • [33] Monotherapy versus combination therapy against carbapenem-resistant Gram-negative bacteria: A retrospective observational study
    Ghafur, A.
    Devarajan, V
    Raja, T.
    Easow, J.
    Raja, M. A.
    Sreenivas, S.
    Ramakrishnan, B.
    Raman, S. G.
    Devaprasad, D.
    Venkatachalam, B.
    Nimmagadda, R.
    [J]. INDIAN JOURNAL OF CANCER, 2016, 53 (04) : 592 - 594
  • [34] Treatment Options for Carbapenem-Resistant Gram-Negative Infections
    Fritzenwanker, Moritz
    Imirzalioglu, Can
    Herold, Susanne
    Wagenlehner, Florian M.
    Zimmer, Klaus-Peter
    Chakraborty, Trinad
    [J]. DEUTSCHES ARZTEBLATT INTERNATIONAL, 2018, 115 (20-21): : 345 - +
  • [35] Treatment Options for Carbapenem-Resistant Gram-Negative Infections
    Bodmann, Klaus-Friedrich
    [J]. DEUTSCHES ARZTEBLATT INTERNATIONAL, 2019, 116 (07): : 115 - 115
  • [36] Carbapenem-resistant gram-negative bacilli in Tripoli, Libya
    Kraiem, Abdulmajeed Ghanem
    Zorgani, Abdulaziz
    Elahmer, Omar
    El Salabi, Allaaeddin Ali
    Ghenghesh, Khalifa Sifaw
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2016, 44 (10) : 1192 - 1194
  • [37] Carbapenem-Resistant Gram-Negative Bacterial Infections in Children
    Aguilera-Alonso, David
    Escosa-Garcia, Luis
    Saavedra-Lozano, Jesus
    Cercenado, Emilia
    Baquero-Artigao, Fernando
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (03)
  • [39] Carbapenem Consumption and Rate of carbapenem-resistant gram-negative bacteria: results from the Sicilian Surveillance System
    Barchitta, M.
    Maugeri, A.
    La Rosa, M. C.
    La Mastra, C.
    Murolo, G.
    Basile, G.
    Agodi, A.
    [J]. ANNALI DI IGIENE MEDICINA PREVENTIVA E DI COMUNITA, 2021, 33 (03): : 289 - 296
  • [40] Effects of screening strategies to detect carbapenem-resistant gram-negative bacteria: A systematic review
    Verdugo-Paiva, Francisca
    Otaiza, Fernando
    Roson-Rodriguez, Pablo
    Rojas-Gomez, Ana Maria
    Galas, Marcelo
    El Omeiri, Nathalie
    Fuentes, Yackelin
    Rada, Gabriel
    Ramon-Pardo, Pilar
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2022, 50 (12) : 1381 - 1388